| Company Name: | U.S. Physical Therapy, Incorporated | | Ticker Symbol: | USPH | | | WWW Address: | www.usph.com | | CEO: | Christopher J. Reading | | No. of Employees: | 1,683 | | Common Issue Type: | CS | | Business Description: | The company operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, rehabilitation of injured workers and neurological-related injuries.
|
| | | Industry Information: | HEALTH SERVICES - Specialized Health Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 15.96 |  -0.06 | 15.94 | 16.01 | 16.29 | 16.30 | 15.12 | 18420 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 186.1 | 11.6 | 1.07 | 0.83 | 0.00 | 16.3 | 0.0 | 17.42 - 6.71 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 16.02 | $ | | PE Ratio - LTM | 16.3 | |
| Market Capitalisation | 186.1 | mil |
| Latest Shares Outstanding | 11.6 | mil |
| Earnings pS (EPS) | 0.83 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 111,519 | $ |
| Effective Tax Rate | 27.6 | % |
| Float | 10.8 | mil |
| Float as % of Shares Outstanding | 93.3 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 28.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 45.1 | % |
| EBITDA Margin | 17.0 | % |
| Pre-Tax Profit Margin | 13.8 | % |
| Assets Turnover | 1.8 | % |
| Return on Assets (ROA) | 10.3 | % |
| Return on Equity (ROE) | 13.5 | % |
| Return on Capital Invested (ROCI) | 12.9 | % |
| Current Ratio | 2.3 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 47.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.05 | |
| LT Debt/Total Capital | 4.0 | % |
| Working Capital pS | 1.74 | $ |
| Cash pS | 0.80 | $ |
| Book-Value pS | 7.47 | $ |
| Tangible Book-Value pS | 2.12 | $ |
| Cash Flow pS | 1.52 | $ |
| Free Cash Flow pS | 1.23 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.14 | |
| Price/Tangible Book Ratio | 7.54 | |
| Price/Cash Flow | 10.5 | |
| Price/Free Cash Flow | 13.0 | |
| P/E as % of Industry Group | 58.0 | % |
| P/E as % of Sector Segment | 71.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 14.1 | 114 | 401 | 1,559 |
| 4 Weeks | 16.74 | 13.46 | 15.48 | 3.5 | 102 | 352 | 7,034 |
| 13 Weeks | 16.91 | 13.46 | 16.04 | -0.1 | 94 | 339 | 21,692 |
| 26 Weeks | 17.42 | 12.44 | 13.26 | 20.8 | 98 | 409 | 51,927 |
| 52 Weeks | 17.42 | 6.71 | 11.53 | 38.9 | 102 | 482 | 121,041 |
| YTD | 17.42 | 6.71 | - | 20.2 | 99 | 458 | 102,944 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 15.74 | 15.52 | 15.70 | 14.65 | 13.52 | 1.07 | 1.22 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 10.82 | 94.0 | 13.25 |
| Income | 10.54 | 68.2 | 20.60 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 42.59 | NA | 35.03 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 8.45 | NA | 11.53 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 8.0 | 8.1 | 23.7 |
| Earnings % | 22.0 | 22.5 | 12.5 |
| EPS % | 23.1 | 23.8 | 10.7 |
| EPS $ | 0.15 | 0.05 | 0.08 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 20.39 |
| Current Ratio | 2.6 |
| Quick Ratio (Acid Test) | 2.5 |
| Liquidity Ratio (Cash) | 0.69 |
| Receivables Turnover | 7.0 |
| Average Collection Period | 51 |
| Working Capital/Equity | 29.5 |
| Working Capital pS | 2.00 |
| Cash-Flow pS | 1.33 |
| Free Cash-Flow pS | 0.43 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.68 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 31.0 |
| Total Debt/Equity (Gearing Ratio) | 0.17 |
| LT Debt/Equity | 0.15 |
| LT Debt/Capital Invested | 23.4 |
| LT Debt/Total Liabilities | 33.9 |
| Interest Cover | 31.5 |
| Interest/Capital Invested | 0.52 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 7.12 |
| Tobin's Q Ratio | 1.57 |
| Current P/E Ratio - LTM | 16.30 |
| Enterprise Value (EV)/EBITDA | 7.12 |
| Enterprise Value (EV)/Free Cash Flow | 70.09 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 7.54 |
| Price/Book Ratio - LTM | 2.14 |
| Price/Cash Flow Ratio | 10.5 |
| Price/Free Cash Flow Ratio - LTM | 13.0 |
| Price/Sales Ratio | 0.94 |
| P/E Ratio (1 month ago) - LTM | 16.4 |
| P/E Ratio (26 weeks ago) - LTM | 15.4 |
| P/E Ratio (52 weeks ago) - LTM | 13.4 |
| 5-Y High P/E Ratio | 36.8 |
| 5-Y Low P/E Ratio | 10.8 |
| 5-Y Average P/E Ratio | 22.4 |
| Current P/E Ratio as % of 5-Y Average P/E | 73 |
| P/E as % of Industry Group | 58.0 |
| P/E as % of Sector Segment | 71.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 16.3 |
| PER SHARE FIGURES |
| LT Debt pS | 1.03 |
| Current Liabilities pS | 1.21 |
| Tangible Book Value pS - LTM | 2.12 |
| Book Value pS - LTM | 7.47 |
| Capital Invested pS | 8.09 |
| Cash pS - LTM | 0.80 |
| Cash Flow pS - LTM | 1.52 |
| Free Cash Flow pS - LTM | 1.23 |
| Earnings pS (EPS) | 0.83 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 2.76 |
| Free Cash Flow Margin 5YEAR AVG | 4.24 |
| Net Profit Margin | 5.3 |
| Net Profit Margin - 5YEAR AVRG. | 5.6 |
| Equity Productivity | 2.30 |
| Return on Equity (ROE) | 12.3 |
| Return on Equity (ROE) - 5YEAR AVRG. | 13.1 |
| Capital Invested Productivity | 2.00 |
| Return on Capital Invested (ROCI) | 10.6 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 12.3 |
| Assets Productivity | 1.70 |
| Return on Assets (ROA) | 8.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | 9.8 |
| Gross Profit Margin | 45.1 |
| Gross Profit Margin - 5YEAR AVRG. | 29.5 |
| EBITDA Margin - LTM | 17.0 |
| EBIT Margin - LTM | 14.0 |
| Pre-Tax Profit Margin | 12.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 13.5 |
| Effective Tax Rate | 27.6 |
| Effective Tax Rate - 5YEAR AVRG. | 27.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 51 |
| Revenue per Employee | 111,519 |
| Net Income per Employee | 5,944 |
| Average Collection Period | 51 |
| Receivables Turnover | 7.0 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.52 |
| Assets/Revenue | 0.59 |
| Net Working Capital Turnover | 7.79 |
| Fixed Assets Turnover | 2.36 |
| Total Assets Turnover | 1.7 |
| Revenue per $ Cash | 18.56 |
| Revenue per $ Plant | 11.85 |
| Revenue per $ Common Equity | 2.30 |
| Revenue per $ Capital Invested | 2.00 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 12.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 12.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |